We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Donor Age Not a Factor in Most Corneal Transplants

By HospiMedica International staff writers
Posted on 26 Nov 2013
Corneas transplanted from a 71-year-old donor are likely to remain as healthy as a cornea from a donor half that age, according to a new study.

Researchers at the Jaeb Center for Health Research (Tampa, FL, USA) and 80 clinical sites across the United States participating in The Cornea Donor Study enrolled 1,090 people eligible for transplants, aged 40–80. More...
The donor corneas, provided by 43 eye banks, were transplanted without respect to patient age via penetrating keratoplasty, in which the central part of the damaged cornea is removed, and a full-thickness donor cornea is sutured in its place. The main outcome of the study was to compare graft survival rates for corneas from two donor age groups aged 12–65 and 66–75.

The results of the study showed that 10-year success rates remained steady at 75% from all donors 34–71 years old; success rates were slightly higher for donors under 34 and somewhat lower for donors over 71. The researcher also found that at 10 years, corneas from donors over age 65 had a slightly higher rate of endothelial cell loss (79%) compared to those from donors age 65 and under (76%). The youngest corneas, from donors age 12–33, had the highest number of cells before surgery and the lowest rate of cell loss at 10 years (67%). The study was published online ahead of print on November 15, 2013, in Ophthalmology.

“Overall, the findings clearly demonstrate that most corneal transplants have remarkable longevity regardless of donor age,” said study coauthor Mark Mannis, MD, chair of ophthalmology at the University of California, Davis (CA, USA). “The majority of patients continued to do well after ten years, even those who received corneas from the oldest donors.”

“The Cornea Donor Study demonstrates the viability of older donor tissue in the majority of cases with endothelial disease. In time, we hope the study will have a lasting impact on the practice of corneal transplant surgery,” added Dr. Mannis. “Although the results suggest that age-matching may be appropriate for the very youngest donors and patients, we do not think it is necessary in the vast majority of cases.”

The researchers concluded that the high success rate for transplants involving donors under age 34 raises the question of whether age matching of donors and recipients is appropriate at the extremes of recipient age, a frequent practice for children and other young patients in need of corneal transplants who routinely seek corneas from young donors. Young donor corneas are relatively rare however, and in 2012, corneal donors under age 31 comprised less than 10% of the US donor pool.

Related Links:

Jaeb Center for Health Research



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.